Targeted Technology Fund II

Targeted Technology Fund II is a venture capital firm focused on early-stage investments in companies that advance groundbreaking or disruptive technologies to significantly improve medical practices and patient outcomes. The firm also favors technologies that enhance the efficiency, cost-effectiveness, or functionality of developing and manufacturing life science products.

The fund concentrates on sectors such as medical devices, life science tools, biotechnology, diagnostics, and specialty pharmaceuticals. It seeks technologies with the potential for a shorter time and lower cost to market, addressing compelling market needs that offer opportunities for enhanced returns.

Targeted Technology Fund II's investment model aligns with the current healthcare and economic environment, favoring innovations that can improve clinical outcomes and patient care while reducing healthcare costs. The firm aims to support companies that are poised to make a significant impact in the healthcare sector through technological advancements.